The European Proteomics Market is expected to grow at a CAGR of 11.2% and reach USD 6.39 billion in 2023 from USD 3.76 billion in 2018. Proteomic is the large-scale study of proteomes. Proteome is complete set of proteins, produced or modified by an organism or system. It studies when and where proteins are expressed, and which proteins causes diseases like cancer and other biological illnesses.
Increasing requirement for customized medicine, R&D use, technological advancements, and increased financing for proteomics ventures are some of the factors driving the Europe market. However, decreasing funds in key markets, sequestration cuts in the U.S. and decreased assets for proteomics research, high cost of instruments and hardware, and lack of talented scientists are some of the major factors restraining the Europe market.
Europe Proteomics Market is segmented on the basis of Instrument, Reagent & Service and Application. Based on Instrument, market is segmented into Protein Microarrays, Spectroscopy, X-ray crystallography, Chromatography, Electrophoresis, Surface Plasmon Resonance, and protein fractionation. Based on Reagent, market is segmented into Protein Microarray Reagents, Spectroscopy Reagents, X-Ray Crystallography Reagents, Chromatography Reagents, Electrophoresis Reagents Immunoassay Reagents, Protein Fractionation Reagent. Based on Service & Software, market is segmented into Analytical Laboratory Services, Data Analysis & Maintenance and Quantitation Services. Based on Application, market is segmented into Clinical Diagnostics, Drug Discovery and other proteomic applications. Based on Protein Microarrays, market is further segmented into Biochips, and Microarray instruments. Based on Spectroscopy, market is segmented into Mass Spectrometry, NMR Spectroscopy, and CD Spectroscopy. Based on Chromatography, market is further segmented into HPLC, ion Chromatography, Affinity Chromatography, Supercritical Fluid Chromatography. Based on electrophoresis, market is further segmented into gel electrophoresis, Capillary electrophoresis. Based on Analytical Laboratory Services, market is segmented into Protein Identification, Protein Separation and Protein Sequencing. Based on Data Analysis & Maintenance, market is segmented into Bioinformatics Databases, Bioinformatics Tools. Based on Biochips, market is further segmented into Protein Chips, Lab-On-Chips (Microfluidics). Based on Microarray Instruments, market is further segmented into Integrated Systems, Arrayers, and Microarray Scanners. Clinical Diagnostics segment accounted for largest share in 2015 owing to the increased understanding of structures of protein expression for drug development and diseases. Drug discovery segment is expected to increase at the highest CAGR owing to continuous search for efficient ways to deliver enhanced drugs. Based on Geography, Europe market is further segmented in to UK, France, Germany Italy and Spain.
Some key players in this market are Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, GE Healthcare, Luminex Corporation, Merck KGaA, PerkinElmer Inc., Thermo Fisher Scientific, Inc., and Waters Corporation.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Instrument
5.2 Reagent
5.3 Service & Software
5.4 Application
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
8.Market Leaders' Analysis
8.1 Agilent Technologies Inc.
8.2 Bio-Rad Laboratories, Inc.
8.3 Bruker Corporation
8.4 Danaher Corporation
8.5 GE Healthcare
8.6 Luminex Corporation
8.7 Merck KGaA
8.8 PerkinElmer Inc.
8.9 Thermo Fisher Scientific, Inc.
8.10 Waters Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
